{
    "2020-12-06": [
        [
            {
                "time": "",
                "original_text": "甘李药业：门冬胰岛素30注射液药品注册处于“审批完毕-待制证”阶段",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "门冬胰岛素",
                        "药品注册",
                        "审批完毕",
                        "待制证"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业披露门冬胰岛素30注射液药品注册进展：处于“审批完毕-待制证”阶段",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "门冬胰岛素",
                        "药品注册",
                        "审批完毕",
                        "待制证"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}